drugset / Trial / NCT07478848
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
Phase 1
Recruiting
14 enrolled
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
This clinical trial assesses whether it is feasible to use radiation therapy with vancomycin prior to CAR T-cell therapy for patients with large B-cell lymphomas
Timeline
- Start
- 2026-05-29
- Primary completion
- 2029-01-01
- Completion
- 2029-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vancomycin | Other / unclassified | 125 mg | Oral |